CVS
CVS Health Corporation
Stock
$85.20−0.49 (−0.57%)Close Oct 1, 2026
| Stock-based compensation (TTM) | YoY | 5-year CAGR | 10-year CAGR |
|---|---|---|---|
| $715M | +34.4% | 6.0% | 8.8% |
| Stock-based compensation (TTM) | $715M |
|---|---|
| YoY | +34.4% |
| 5-year CAGR | 6.0% |
| 10-year CAGR | 8.8% |
Stock-based compensation
| Period | Stock comp | YoY |
|---|---|---|
| 2025 | $535M | −0.9% |
| 2024 | $540M | −8.2% |
| 2023 | $588M | +31.5% |
| 2022 | $447M | −7.6% |
| 2021 | $484M | +21.0% |
| 2020 | $400M | −11.7% |
| 2019 | $453M | +61.8% |
| 2018 | $280M | +19.7% |
| 2017 | $234M | +5.4% |
| 2016 | $222M | −3.5% |
| 2015 | $230M | +39.4% |
| 2014 | $165M | +17.0% |
| 2013 | $141M | +6.8% |
| 2012 | $132M | −2.2% |
| 2011 | $135M | −10.0% |
| 2010 | $150M | −9.1% |
| 2009 | $165M | +79.3% |
| 2008 | $92M | +17.9% |
| 2007 | $78M | — |